Status:
UNKNOWN
Platelet-rich Fibrin and Grooving for Sagittal Split Osteotomy
Lead Sponsor:
Jesse Han
Conditions:
Inferior Alveolar Nerve Injury
Nerve Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sagittal split osteotomy (SSO) is a common operation done to move the mandible to correct dentofacial deformities and obstructive sleep apnea (OSA). Inferior alveolar nerve (IAN) injury and associated...
Eligibility Criteria
Inclusion
- Inclusion criteria include patients ages 18 and older, male or female, with a diagnosis of dentofacial deformity and/or OSA who will undergo BSSO.
Exclusion
- Exclusion criteria include patients with a history of previous mandibular surgery and preoperative neurosensory dysfunction of the trigeminal nerve. Other exclusion criteria are patients without capacity to consent for themselves or unable to read the consent form. Subjects who have conditions which may impair healing (such those on bisphosphonates treatments, blood thinners, corticosteroids, chemotherapy, etc.) will be excluded from participation in the research.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04706182
Start Date
February 1 2021
End Date
December 31 2024
Last Update
January 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dale S. Bloomquist, DDS, MS
Seattle, Washington, United States, 98101